ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.750,92
-0,31%
S&P 500
5.308,13
0,09%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
71.154,38
-0,41%
Brent Oil
83,10
-0,51%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Amryt Pharma Plc (AMYT)

  7. Amryt Pharma Plc (AMYT) Notícias

AMYT

Amryt Pharma (AMYT)

Amryt Pharma Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:AMYT
DataHoraFonteTítuloCódigoCompanhia
11/01/202211:39Alliance NewsAlliance NewsIN BRIEF: Amryt Pharma delists from AIM as trading shifts to New YorkLSE:AMYTAmryt Pharma Plc
06/01/202214:29UK RegulatoryFTSE Russell Amryt PharmaLSE:AMYTAmryt Pharma Plc
06/01/202204:00UK RegulatoryAmryt Pharma plc Key Dates For Aim DelistingLSE:AMYTAmryt Pharma Plc
04/01/202209:00UK RegulatoryAmryt Pharma plc The Lancet Diabetes & Endocrinology Publishes Positive Results For The Mpowered Phase 3 Trial For Mycapssa(R) (oral octreotide) In Acromegaly PatientsLSE:AMYTAmryt Pharma Plc
04/01/202204:00UK RegulatoryAmryt Pharma plc Total Voting RightsLSE:AMYTAmryt Pharma Plc
30/11/202104:00UK RegulatoryAmryt Pharma plc Director/Pdmr ShareholdingLSE:AMYTAmryt Pharma Plc
23/11/202110:21Dow Jones NewsAmryt Pharma Says FDA Extends Oleogel-S10 New Drug Application Review by Three MonthsLSE:AMYTAmryt Pharma Plc
23/11/202109:00UK RegulatoryAmryt Pharma plc Amryt Provides Update On Regulatory Review Process For Oleogel-S10LSE:AMYTAmryt Pharma Plc
22/11/202104:00UK RegulatoryAmryt Pharma plc Amryt Announces The Cancellation Of Admission Of Its Ordinary Shares To Trading On AimLSE:AMYTAmryt Pharma Plc
09/11/202119:01Alliance NewsAlliance NewsTRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pillLSE:AMYTAmryt Pharma Plc
03/11/202108:00UK RegulatoryAmryt Pharma plc Amryt Reports Strong Q3 2021 ResultsLSE:AMYTAmryt Pharma Plc
01/11/202104:00RNS Non-RegulatoryAmryt Pharma PLC Amryt Supports Acromegaly Awareness DayLSE:AMYTAmryt Pharma Plc
22/10/202103:00RNS Non-RegulatoryAmryt Pharma PLC Amryt Supports Global EB Awareness Week 2021LSE:AMYTAmryt Pharma Plc
20/10/202108:00UK RegulatoryAmryt Pharma plc Amryt To Report Q3 2021 Results And Host Conference Call & Webcast On November 3LSE:AMYTAmryt Pharma Plc
19/10/202108:00UK RegulatoryAmryt Pharma plc Amryt Announces New Patents For Oleogel-S10 And Mycapssa(R)LSE:AMYTAmryt Pharma Plc
23/09/202107:59RNS Non-RegulatoryAmryt Pharma PLC Amryt Supports Global FH Awareness DayLSE:AMYTAmryt Pharma Plc
14/09/202103:32Alliance NewsAlliance NewsIN BRIEF: Amryt Pharma ups guidance again after Chiasma acquisitionLSE:AMYTAmryt Pharma Plc
13/09/202108:00UK RegulatoryAmryt Pharma plc Amryt Raises Full Year 2021 Revenue Guidance To $220m - $225mLSE:AMYTAmryt Pharma Plc
19/08/202103:00UK RegulatoryAmryt Pharma plc Amryt Issues Ordinary Shares And Total Voting RightsLSE:AMYTAmryt Pharma Plc
13/08/202109:23UK RegulatoryAmryt Pharma PLC Holding(s) in Company - ReplacementLSE:AMYTAmryt Pharma Plc
11/08/202107:30UK RegulatoryAmryt Pharma PLC Holdings in CompanyLSE:AMYTAmryt Pharma Plc
11/08/202106:36UK RegulatoryAmryt Pharma PLC Holding(s) in CompanyLSE:AMYTAmryt Pharma Plc
09/08/202108:00UK RegulatoryAmryt Pharma plc Amryt Virtual Capital Markets Event - September 13, 2021 -- 1000-1200 EdtLSE:AMYTAmryt Pharma Plc
06/08/202110:41Alliance NewsAlliance NewsIN BRIEF: Amryt hikes guidance on record second quarter resultsLSE:AMYTAmryt Pharma Plc
06/08/202108:00UK RegulatoryAmryt Pharma plc Amryt Reports Record Q2 2021 Results And Raises Fy 2021 GuidanceLSE:AMYTAmryt Pharma Plc
05/08/202111:50UK RegulatoryAmryt Pharma plc Amryt Successfully Completes Acquisition Of Chiasma, Inc., Board Appointments, Issues Ordinary Shares And Total Voting RightsLSE:AMYTAmryt Pharma Plc
28/07/202111:00UK RegulatoryAmryt Pharma plc Result Of General MeetingsLSE:AMYTAmryt Pharma Plc
12/07/202108:00UK RegulatoryAmryt Pharma plc Amryt To Report Q2 2021 Results And Host Conference Call & Webcast On August 6LSE:AMYTAmryt Pharma Plc
28/06/202108:00UK RegulatoryAmryt Pharma plc Publication Of Circular To Amryt Shareholders In Relation To The Acquisition Of Chiasma, Inc., And Posting O...LSE:AMYTAmryt Pharma Plc
15/06/202107:45UK RegulatoryAmryt Pharma plc Amryt Pharma Announces Filing Of Preliminary Registration Statement On Form F-4 In Connection With Its Propo...LSE:AMYTAmryt Pharma Plc
 Apresentando as notícias mais relevantes sobre:LSE:AMYT

Seu Histórico Recente

TSXV
BMN.A
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados